Hepatoprotective activity of the biologically active additive "Darmonal" in toxic hepatitis

The incidence of hepatopathy in the world population has been continuously growing in recent years. Experts attribute this phenomenon to various factors: alcoholism, drugs, blood transfusions, iatrogenesis, infectious processes, and others. The search for new hepatotropic drugs is also relevant against the background of new viral infections. It has been established that the causative agent of a new coronavirus infection can lead to the development of virus-mediated hepatopathy [2, 5]. The pathogenesis of this liver lesion remains a subject of debate, but scientists consider the “cytokine storm” that develops during severe and very severe infectious process as a leading factor in this process [2].